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ABSTRACT 
The Experiencing Scale (EXP), a measure of client's emotional processing, is often used in 
psychotherapy process research. While researchers agree that it predicts treatment 
outcomes, this relationship has not been systematically studied. This meta-analysis 
quantified the relationship between EXP and therapy outcomes using a total of 11 studies 
and 458 clients. Analysis indicated that peak EXP measured during the working phase was 
the strongest predictor of treatment outcomes, r = .236. Subgroup analyses indicated that 
working phase effects were moderated by the outcome measure modality. Early phase 
effects were moderated by the type of treatment and the treatment target. In accordance 
with the literature in the field, working phase EXP was found to be a significant predictor 
of clinical outcomes, although this relationship was influenced by a number of variables. 
Further research should look at the moderators between EXP and outcomes, and at 
processes that increase client experiencing.  
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CHAPTER 1 
Introduction 
Some processes that occur during a psychotherapy session seem to hold promise for 
understanding how psychotherapy works. One such process is the depth with which 
clients experience their emerging feelings and thoughts (Greenberg & Pascual-Leone, 
2006). Yet, no reviews have been conducted in the literature that might allow for an 
estimate of how important this particular process may be. In the hopes of addressing this 
question, the goal of the current study is to evaluate the role that a client’s depth of 
experiencing plays in improving his or her outcome in psychotherapy. This introduction 
begins with a review of different types of psychotherapy research, outlining the major 
areas of outcome vs. process research. Next, I discuss the nature of process variables and 
common factors and explain their importance to understanding how psychotherapy 
works. Finally, I present a rationale for the current study, how it is embedded in the 
context of current psychotherapy research, and the intended impact of the study being 
proposed. 
Over 30 years of studies and a multitude of meta-analyses have demonstrated the 
effect that psychotherapy interventions have on clients’ treatment outcomes, and the 
evidence shows that therapy is superior to no treatment (Joyce, Wolfaardt, Sribney, & 
Aylwin, 2006; Budd & Hughes, 2009). Indeed, by several estimations the effect of 
psychotherapy is .8 standard deviations over no treatment (Lambert, 2005). While it is 
certain that therapy is better than no treatment, why it is effective is largely a mystery. 
Furthermore, a number of meta-analyses show evidence for the Dodo Bird effect: the 
finding that different psychotherapies are equally effective. At the same time, a few 
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studies also point to the superiority of certain intervention modalities for specific 
disorders and yet, differential processes are not usually identified (Joyce et al., 2006; 
Budd & Hughes, 2009). In any case, the Dodo Bird effect poses a significant problem for 
the field of psychotherapy. If seemingly disparate psychotherapies produce very similar 
outcomes, how does therapeutic change occur? 
While studying the effectiveness of interventions and their comparative efficacy has 
led to the establishment of evidence-based practices, outcome research alone does not 
explain how therapy works or why outcomes are so similar (Garfield, 1990; Joyce et al., 
2006). These questions, however, are the purview of “process research”. Finding 
processes through which therapy enacts change is doing a great service to empirically 
supported treatments; it adds the understanding that treatments work, but also which 
treatment components produce change, and which do not. It is possible then, through 
further research, to improve treatments and clarify them by removing any time-
consuming procedures that do not produce change while emphasising those components 
that do. 
Process research is an effort to explicate the causal processes of therapy that lead to 
change and addresses the shortcomings of outcome research (Joyce et al., 2006). 
Research and theory in this field has come to describe two general factors of change, 
treatment factors (i.e., interventions specific to a psychotherapy school such as insight or 
exposure) and common factors, which are ubiquitous to psychotherapy in general (i.e., 
client, therapist, the dyadic relationship, and general therapeutic process variables). There 
is an ongoing controversy in process research that revolves around these two kinds of 
factors and their relative contribution to outcomes (Nathan, 2004). 
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Rosenzweig (1936) was the first to propose the common factors idea that became 
increasingly popular in psychotherapy research, influencing psychologists such as Carl 
Rogers to elaborate his idea of the relationship as an overarching factor (Duncan, 2002). 
Common factors are also thought to be at least partly responsible for producing the Dodo 
Bird effect. Today, cumulative meta-analytic findings do indeed point towards the 
existence of common processes and mechanisms of change operating across therapies 
and which predict their eventual treatment outcome (Joyce et al., 2006; Budd & Hughes, 
2009). Before proceeding with the overview of common factors of change, however, it is 
important to understand the relevant terminology and how it has evolved.  
Common Factors of Change  
The strongest explanation of equal effectiveness among psychotherapies is the notion 
of factors that are empirically related to change but are not predicted or explained by 
theory underlying a given psychotherapeutic modality and yet, on closer examination, are 
present in most interventions (Oei & Shuttlewood, 1996). Three terms are usually used to 
describe such factors: placebo effect, nonspecific factors, and common factors.  
Some have suggested that the placebo effect is an inappropriate term in a non-
medical context, and that it also bears some negative connotations, thus downplaying the 
importance of some such processes of change (Oei & Shuttlewood, 1996). In medical 
context, a placebo is a psychological or psycho-physiological effect produced by the 
administration of an inert substance. In treatment research, such effects will be 
considered unwanted systematic variance by any researcher who looks for treatment-
specific psychological mechanisms of change (Oei & Shuttlewood, 1996). Moreover, 
studies have shown that placebo control groups improve more than no-treatment groups 
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albeit less than treatment groups (Lambert, 2005), effectively demonstrating that the 
effect of psychotherapy reaches beyond that of a placebo alone. 
Another formulation of variables of change underlying most psychotherapies is the 
notion of a nonspecific factor. This formulation is in contrast to the treatment specific (or 
technique) factors, and although nonspecific factors are conceptually more broad, the 
construct unfortunately tends to be reduced to no more than interpersonal and relationship 
factors (Castonguay & Holtforth, 2005). Consequentially, some studies have been 
criticized as placing relationship factors (such as therapeutic alliance) in the spotlight, 
while leaving out non-relationship factors responsible for change (Castonguay & 
Holtforth, 2005). 
Finally, the truly common factor formulation has been outlined by Castonguay and 
Grosse Holtforth (2005). This formulation refers to those variables that operate across 
therapies, are not necessarily limited to the therapeutic alliance, such as facilitating new 
meaning-making and providing corrective experiences (Castonguay & Grosse Holtforth, 
2005). 
To place these issues in context one must consider the outcome literature at large, 
which indicates that therapeutic techniques account for no more than 10% of the variance 
in symptom change, while therapeutic alliance, the most well- researched and reliable 
measure of the relationship common factor, accounts for approximately the same amount 
(Castonguay & Beutler, 2006). 
A recent APA Task Force has identified a number of treatment and common factors 
across dysphoric, anxiety, personality, and substance use disorders, as well as factors that 
only pertain to specific diagnostic categories (Beutler, Castonguay, & Follette, 2006; 
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Newman & Stiles, 2006; Critchfield & Benjamin, 2006; Haaga, McCrady, & Lebow, 
2006). Therapeutic alliance, in particular, is perhaps the most robust and well-researched 
common factor. It can be conceptualized as an agreement between the client and the 
therapist on general goals of therapy, and specific tasks to accomplish those goals, as well 
as an emotional bond between the two individuals (Bordin, 1979). In a meta-analysis of 
79 studies, the therapeutic alliance was found to be moderately but consistently related to 
outcome (Martin, Garske, & Davis, 2000). Therapeutic alliance is such a pervasive 
variable that it seems to eclipse other common factors and is used interchangeably with 
the broader term, as Castonguay and Grosse Holtforth (2005) pointed out. 
While there is some progress towards identifying working process components of 
therapy (e.g., alliance), others have been largely overlooked. The depth of a client’s 
experiencing, for example, is one variable that does not fit the participant characteristics 
identified in previous APA Task Forces on the study of common factors (Castonguay & 
Grosse Holtforth, 2005). 
Client Experiencing as a Probable Common Factor 
Depth of experiencing refers to the emerging moment-by-moment integration of 
cognitions and affect, emotional arousal and emotional processing operating in tandem 
(Klein, Mathieu-Coughlan, & Kiesler, 1986). A deep level of experiencing is the process 
of making new meaning based on information derived from pre-verbal affective/meaning 
experiences that are attended to in the moment, what Gendlin (1981) also referred to as a 
felt sense. This in-the-moment process is different from simple emotional arousal 
(catharsis) or from purely cognitive processing of events in the absence of arousal. 
Operationalization of the experiencing construct is rooted in humanistic and experiential 
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approaches to psychotherapy, but as a new line of research studies has begun to suggest 
(e.g., Watson & Bedard, 2006), its application is not limited to these traditions. A similar 
concept is represented by emotional engagement or emotional processing in both the 
behavioural and cognitive approaches (Whelton, 2004). Over the recent years, this has 
also been receiving increasing attention in newer forms of psychodynamic psychotherapy 
(Whelton, 2004; Fosha, 2000). 
While the initial process construct can seem somewhat abstract, a scale has been 
developed to assess a given depth of experiencing. The client Experiencing scale (EXP; 
Klein, Mathieu-Coughlan, & Kiesler, 1986) is a Likert-type, 7-point scale that uses 
trained raters to measure the depth of client’s experiencing. To date, it is one of the most 
studied and validated measures of productive in-session process available in 
psychotherapy research, and it is often considered among scientist-practitioners to be a 
gold standard of measuring good experiential process (Greenberg & Pascual-Leone, 
2006), although one would be hard-pressed to find an alternative measure that addresses 
the same construct. 
Since the forays of psychotherapy process research, studies have used EXP in a 
number of different ways. Some have looked at EXP as a moment-by-moment outcome 
measure of good therapeutic process. In micro-process research of this kind, often 
referred to as process-to-process research, the focus is on measuring effects within a 
given session or moment. For example, Silberschatz, Fretter and Curtis (1986) 
investigated the effect of therapist’s interpretations on client’s productivity in the context 
of brief psychodynamic therapy; where client productivity was measured by a subsequent 
increase in EXP ratings (i.e., a positive impact on client’s in-session work). Similarly, 
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Greenberg and Rice (1981) found that a gestalt two-chair intervention (i.e., enacting an 
imaginary dialogue with oneself) increased client’s EXP, with implications for the client 
having a greater ability to cope with and resolve intrapersonal conflict. In another 
example, Macaulay, Toukmanian and Gordon (2007) found that when therapists showed 
greater empathy in emotion-focused psychotherapy, it also predicted higher levels of 
client’s EXP. A number of studies from different schools of psychotherapy have used 
EXP as a measure of good in-session outcome on the theoretical assumptions that the 
process is important, and that the accumulation of these kinds of good moments actually 
yield good treatment outcomes later on. This leads to the empirical question: does EXP 
truly have practical importance? 
Since the inception of this measure of experiential engagement, over a 100 studies 
internationally have used EXP in some capacity, as Hendricks (2009) pointed out in her 
broad review on this measure. While this is an impressive number, most of these studies 
are quite diverse in their purpose and research questions, such that most of them do not 
hope to use EXP as a predictor of post-treatment clinical outcomes. Nonetheless there is a 
small number of carefully designed studies that do specifically look at the relevance of 
EXP as a process variable predictive of final treatment outcome. Those studies are not 
limited to only humanistic or experiential psychotherapies (Greenberg & Pascual-Leone, 
2006). For example, Goldman, Greenberg and Pos (2005) found that, in both client-
centered and in emotion-focused psychotherapies, greater EXP during sessions was 
predictive of reduced symptoms of depression and increased self-esteem upon treatment 
completion. In a 12-week program of cognitive therapy, Castonguay, Goldfried, Wiser, 
Raue, and Hayes (1996) found that greater EXP during treatment was predictive of 
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improvement in depressive symptoms at the end of treatment. Similarly, in a comparative 
study of cognitive behavioural and emotion-focused therapies, Watson, McMullen, 
Prosser and Bedard (2011) again showed that, in both treatments, greater EXP was 
predictive of the following outcomes: decreased symptoms of depression, fewer 
interpersonal problems, less general psychological distress, as well as reduced 
dysfunctional attitudes and increased self-esteem. Interestingly, they also found that 
clients’ affect regulation fully mediated the relationship between EXP and those 
outcomes. 
The role of high EXP also seems important to treatments that emphasize 
interpersonal changes. Johnson and Greenberg (1988), in a study on emotionally focused 
therapy for couples, found that greater EXP for both partners was also characteristic of 
the most productive sessions of those couples who were most successful in therapy. 
Rudkin, Llewelyn, Hardy, Stiles and Barkham (2007) in their study that contrasted 
cognitive-behavioral therapy (CBT) and psychodynamic- interpersonal therapy (PI) found 
that PI therapy clients with good outcomes had higher levels of EXP than those that did 
not. 
Finally, while there is clear evidence of the beneficial effects of psychotherapy on 
outcomes, the fact that gains are sometimes reversed or that clients may eventually 
relapse, still remains problematic (Ellison, Greenberg, Goldman, & Angus, 2009). It 
follows one of the aims of process research that that seeks to identify and facilitate good 
processes is because it may lead to an understanding of how to maintain treatment gains. 
So, establishing EXP as an index of a good psychotherapeutic process becomes important 
avenue of inquiry in this field and potentially for various ends. 
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Thus, research on process, outcome, and even some hypotheses about non-relapse 
have suggested that EXP may be a key construct with practical importance. Even so, 
despite this evidence, no systematic evaluation has been conducted to compile the 
evidence that EXP is a significant process variable as well as a probable common factor. 
So, while EXP is widely considered to be a gold standard and is believed to be predictive 
of outcomes, one would be hard pressed to find and cite a summative piece of research to 
that effect. One of the difficulties entailed in this task is that studies that have used EXP 
as a measure vary in their methodology and samples, among other characteristics, and 
EXP has been used in many ways across the literature. Summarizing the research 
findings to date on the general effect of EXP and its generalizability across treatment 
approaches would be helpful for the field by establishing client’s depth of experiencing 
as an important process variable in psychotherapy.  
Rationale for the Current Study 
The rationale of this study is in line with the general aims of process research: to 
identify what processes are related to, or cause, therapeutic changes to occur in the 
eventual service of good treatment outcomes. Finding process variables that go beyond 
the therapeutic alliance, especially if they generalize across therapeutic modalities, is 
helpful in informing the field of psychotherapy for both future research and practice. In 
the case of this particular study, there is a need to compile and examine the mounting 
evidence that EXP is an important predictor in its own right, as well as a probable 
common factor.  
Showing that the depth of client experiencing is conclusively relevant across diverse 
treatment approaches is a key issue of inquiry because of its potential implications for 
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theory and intervention across different psychotherapy approaches. While interventions 
from a number of approaches provide explicit tasks such as evaluating maladaptive 
cognitions, deepening experience is a more implicit task that could transcend a host of 
other front- line interventions. While humanistic and experiential approaches have 
cultivated their intervention approaches to facilitate this, deepening experience is a matter 
of intention rather than a specific intervention per se, thus it is completed by the client 
and often facilitated through the manner in which an open-ended intervention is applied. 
Such a general intervention strategy may be applicable to most established treatments 
without interfering too much with their specific techniques, although some techniques 
would likely be more compatible with this additional implicit objective than others (e.g., 
interventions for facilitating insight, meaning-making, and awareness are highly 
compatible, while highly directed and behavioural tasks may not be). Having clear 
evidence about the impact of depth of client’s experiencing on symptoms will be useful 
in developing new interventions and perhaps even in retrofitting established ones.  
This proposed direction of research would also be useful, first of all, in shoring up 
the claims held by the growing body of existing process research that has used the EXP 
as an in-session outcome. At the same time it would be providing a foothold for future 
research of other key processes that may have been overlooked.  
The first step in a research study on EXP is to compile and examine evidence 
supporting the notion of this variable as a probable common factor. There is some initial 
support for this idea (see Hendricks, 2009), and if a meta-analysis supports it, a 
promising research direction would be opened: the systematic study of which therapist 
processes or interventions lead to increasing client’s EXP. In other words, the current 
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study could lead to practice-relevant implications for helping clinicians improve 
treatment outcomes for their clients. Furthermore, because process research usually relies 
on correlational designs (Joyce et al., 2006; Elliott, 2010), the current study might 
encourage experimental process research or help researchers answer Elliott’s (2010) call 
for the use of more sophisticated statistical procedures such as structural equation 
modeling, which are naturally more demanding and complex. Without evidence from a 
systematic review showing the role of EXP, such studies on client process may never be 
conducted. 
Rationale for the Method 
Hendricks (2009) has already provided an valuable narrative review on EXP and 
indicated that EXP was correlated with various psychotherapy outcome measures across 
studies. As indicated, other authors (e.g., Greenberg & Pascual-Leone, 2006) have further 
indicated that a small number of well designed process-to-outcome studies collectively 
suggest there may a broader effect of EXP that is waiting to be indexed. It follows then 
that given EXP is an important predictor of therapeutic outcome and regarded by many 
process researchers as a gold standard, the question of this study is: What is the actual 
general effect of deeper levels of experiencing? And, furthermore, does it generalize 
across studies with different characteristics? While a number of individual studies have 
been conducted in this area, replication in Psychology does not often lead to definitive 
results (Berkeljon & Baldwin, 2009). A meta-analysis, on the other hand, is a quantitative 
technique that allows one to address that problem by drawing upon data gathered from 
existing studies to answer research questions (Berkeljon & Baldwin, 2009). In doing so, a 
meta-analysis goes beyond a single sample, addressing the issue of research replication 
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and the generalization of findings across different populations. Because I hypothesize that 
study characteristics influence outcome, a meta-analytic approach provides additional 
research leverage (Berkeljon & Baldwin, 2009).  With this approach it is possible to 
examine whether factors such as study design (experimental vs. quasi-experimental), 
clinical population or treatment type, or the method of outcome measurement have an 
effect on study findings. This breakdown of study- level covariates must be very selective 
and is limited by the number and size of study characteristics that can be coded.  
Current Study 
This study relates client process to outcome. Greenberg (1986) postulated that 
outcomes in psychotherapy can be looked at three levels: immediate, intermediate, and 
ultimate outcomes. Immediate outcomes refer to a micro level change occurring within a 
single session, distinguishing good vs. poor therapeutic events (i.e., a productive moment 
in time or the success of a given intervention). At a slightly wider scope, intermediate 
outcomes refer to a broad pattern of change typically measured by session outcome 
measures, such as clinically relevant change in a client’s attitudes and behaviours, 
distinguishing good vs. poor therapy sessions. Finally, ultimate outcomes are assessed at 
the end of therapy and at follow-ups. This scope of analysis paints the overall picture of 
clinical change and distinguishes a good vs. poor (i.e., successful vs. unsuccessful) course 
of psychotherapy. Both immediate and intermediate outcomes have been conceptualized 
as small o’s, while the ultimate outcomes have come to be referred to as large O’s 
(Greenberg & Pinsof, 1986). A complete description of the change process requires the 
study of all three levels of change and their relationships: how immediate outcomes 
influence intermediate outcomes, and later how these influence ultimate outcomes 
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(Greenberg, 1986). Previous research has studied EXP in two ways: as an outcome in 
itself (small o) brought about by other therapeutic processes (e.g., as therapist 
interventions or client insights), and as a process that predicts therapy outcomes (large 
O). To our knowledge no studies examined both roles of EXP simultaneously, although 
these can often be represented as different studies within a program of research. The 
current meta-analysis deals with the ultimate outcomes: how EXP is related to outcome 
measures at the end of therapy. This model is presented in Figure 1. Note that there is a 
possibility that the relationship between EXP and outcomes is moderated by other 
variables. In other words, contextual variables may change the relationship between EXP 
and outcome. 
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Figure 1. The meta-analytic model. 
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Research Questions  
This study is concerned with the following three questions: 
1. Does EXP predict therapeutic outcomes? It is hypothesized that EXP positively 
predicts outcomes, such that as EXP increases, psychotherapy outcomes improve. 
2. Is predictive power of EXP equal across therapeutic modalities? It is anticipated 
that this process variable successfully generalizes across different treatment 
approaches. 
3. Are there variables that moderate the relationship between EXP and the clinical 
outcomes? 
CHAPTER 2 
Methods  
This meta-analysis followed Berkeljon and Baldwin’s (2009) outline of a number of 
steps for data synthesis, specifically with respect to psychotherapy outcome research. I 
will briefly present them, and then go on to explain how these steps are applied in the 
current study. (1) Research starts with a problem formulation, identical to how a 
conventional research study would proceed. This first step has been elaborated in the 
introduction of this document (above). The next step (2) is a literature search, given that 
“participants” in a meta-analysis are individual studies drawn from existing literature. 
Choosing studies with the right characteristics to address the research problem is 
essential. After the studies that qualify for a meta-analysis are gathered, (3) relevant data 
is extracted from them. Finally, (4) extracted data is subjected to statistical analysis and 
interpretation to answer the problems formulated at the beginning of the process. 
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Literature Search 
The literature search was conducted using PsycInfo, ERIC, Medline, and Social 
Sciences Abstracts databases. The following search terms were used: experiencing scale, 
emotional experiencing, client experiencing, patient experiencing, depth of experiencing, 
psychotherapy, psychotherapeutic processes, and EXP. However, because publication 
bias is an ever-present threat to the validity of meta-analysis (Berkeljon & Baldwin, 
2009), we have contacted researchers to access additional unpublished material. This was 
done by making two open requests on well known research listserves with international 
memberships such as the listserv for the Society for Psychotherapy Research, the Society 
for the Exploration of Psychotherapy Integration, and the Short Term Dynamic 
Psychotherapy. Furthermore, direct inquiry was made to key researchers who were 
known to be involved in the use or study of the EXP. For the full list of contacted 
researchers see Appendix A. 
Once the studies were collected, the following criteria were used to evaluate the 
suitability of each study for inclusion in the meta-analysis: (a) a given study must 
measure relevant constructs (both in-session EXP and clinical treatment outcomes), (b) it 
must feature a clinical population (i.e., participants with target clinical concerns such as 
Axis I and/or Axis II diagnosis), (c) it must report effect sizes or entail data that is 
convertible to effect sizes, of the relationship between EXP and treatment outcome, and 
finally (d) the included studies must have non-overlapping data sets. This last criterion is 
especially necessary because psychotherapy process research often relies on archival data 
from outcome studies; hence, one must take precautions to avoid the risk of redundancy 
in data. As it happened, a number of existing studies on the EXP have apparently drawn 
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from the same or similar archival databases (this is particularly the case at the York 
Psychotherapy Research Centre, Ontario Institute for Studies in Education (OISE), and 
University of Ottawa). Redundant data poses a very significant risk of biasing the meta-
analytic results, because it violates the statistical assumption of independence of 
observations, which results in an overestimate of the mean effect and its precision 
(Wood, 2008). One of the corrections for this problem proposed in the methodological 
literature is to exclude the duplicates and only use the “main” article, the article with the 
largest data set (Wood, 2008). In the current study, research authors were personally 
contacted and consulted as needed regarding the potential overlap of their relevant data 
sets. 
Coding 
Retrieved studies were coded independently by two researchers for the following 
information: (a) Treatment characteristics: treatment modality, treatment form, duration 
of treatment, intensity of treatment, therapist experience; (b) methodological 
characteristics: random assignment, blindness of EXP raters, presence of control groups, 
transcript sampling media, session EXP sampling method, within session EXP sampling 
method; (c) extrinsic characteristics: publication status, country of publication; (d) EXP 
characteristics: EXP type (mode, peak), EXP timing (early, working phase), percent of 
EXP data checked for reliability, hours of EXP rater training, EXP reliability ratings; (e) 
process measures and their reliabilities; (f) outcome measures; (g) effect sizes. 
After all of the studies were coded by the primary researcher, the inter-rater 
agreement was assessed by the author and an undergraduate assistant. The assistant 
received two hours of training on the coding procedures on two of the 11 studies that 
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were used for the meta-analysis. Three of the studies were not coded for agreement 
because, following our request, the researchers sent the original SPSS data files, and two 
more were not checked for reliability because the effect sizes had to be computed from 
the raw data. 
The second rater, the undergraduate assistant, conducted reliability check for 4 
studies (36% reliability sample). Inter-rater agreement was r = .731 for a total of 24 effect 
sizes. The only discrepancy appeared to be a missed negative sign for one of the origina l 
t-values, agreed to be a typo. Inter-rater agreement on timing of EXP (i.e., early or 
working phase), however, was low (kappa = .406), mostly due to difficulties in coding 
experiencing timings for clinical judgment studies that were not always clearly indicated. 
Agreement was perfect on treatment approach and treatment publication status. However, 
the rater was confused by the type of reliability coefficients the studies reported. While 
the numerical values matched, the types (i.e., ICC, Kappa) did not. A third rater, a senior 
researcher, coded treatment target reliability across all studies, resulting in excellent 
agreement (kappa = .783). All disagreements were resolved by consensus. Finally, 
clinical judgment emerged as an unexpected moderator during analysis, and therefore no 
inter-rater agreement rating was calculated for it. Clinical judgment codes were assigned 
to studies through a consensus with a senior researcher.  
Data Analysis 
All analyses followed the methods outlined by Borenstein, Hedges, Higgins, and 
Rothstein (2009) and were computed in MS Excel 2007. Some analyses were re-checked 
with Comprehensive Meta-analysis (Version 2) software developed by Borenstein, 
Hedges, Higgins, and Rothstein (2005).  
 19 
 
 
 
Publication Bias.  
Publication bias is an ever-present threat to a meta-analysis. While the methodology 
tried to address it by searching for unpublished material, it was important to evaluate 
whether such a bias is still present. In the current study, this was done through Orwin’s 
Fail-safe N (Zakzanis, 2001). This statistic represents the number of hypothetical studies 
that, if added to already existing studies, will turn the result into a trivial effect size of r = 
.09 or Cohen’s d = 0.20, a convention proposed by Cohen (Zakzanis, 2001). 
Choice of a Statistical Model.  
Meta-analyses can be conducted using either a fixed-effect or random-effects 
statistical model. A fixed-effect model assumes that the participant studies estimate the 
same true population effect size, with individual study differences being due to sampling 
error. A random-effects model assumes that different studies estimate different true 
population effects (Baker et al., 2009). Because a fixed-effect model does not take into 
account between study variability, which was expected due to clinical and 
methodological diversity (Thompson & Higgins, 2002), the random-effects model was 
more appropriate for the current study (see Baker et al., 2009). In addition, the goal of 
this meta-analysis was to generalize beyond the current sample, which a random-effects 
model is best suited for (Berkeljon & Baldwin, 2009). 
Weighting. 
Because a meta-analysis pools effect sizes from multiple studies, each with different 
characteristics, it is important to weight those individual effect sizes relative to the 
contribution of the study from which each effect size came. This ensures, for example, 
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that smaller studies with large variance do not have an undue influence on the results of 
the analysis. Given the random-effects model, each effect size will be weighted by the 
inverse of the sum of within-study variance and between-study variance (Hedges & 
Vevea, 1998). A Monte Carlo simulation study has shown that when the random-effects 
assumption is true, the weighting method of Hedges and Vevea produces more precise 
estimates than an alternative of weighing by sample size (Marin-Martinez & Sanchez-
Meca, 2009). If the random-effects assumption does not hold, however, the model is 
reduced to fixed-effects automatically (Borenstein et al., 2009).  
Homogeneity of effect sizes.  
Diagnostics included a test for the homogeneity of effect sizes, or the assumption 
that effect sizes are dispersed around the mean to a degree no greater than what is 
expected due to sampling error alone. This is typically assessed by the Q test (Berkeljon 
& Baldwin, 2009). Statistical heterogeneity of effect sizes indicates that studies represent 
samples from different populations, rather than one uniform population (Baker et al., 
2009), which might be expected given the diverse clinical and methodological nature of 
the studies in current research. Moreover, a Q test tends to be underpowered with small 
samples (Huedo-Medina, Sanchez-Meca, Marin-Martinez, & Botella, 2006), and even 
when it indicates a lack of heterogeneity, uneven patterns of variance can still be present 
(Hardy & Thompson, 1998). From what the practice of meta-analyses indicates, some 
heterogeneity will always be present, regardless of whether the Q test identifies its 
presence or not (Thompson & Higgins, 2002). Thus, a complementary statistic, I2 
(Huedo-Medina et al., 2006; Sutton & Higgins, 2008) was also used to evaluate the 
extent of heterogeneity in the current study. Such heterogeneity may indicate an influence 
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of study- level characteristics (moderators) and is usually tested through a subsequent 
subgroup analysis. 
Hypothesis Testing: A Summary of Principal Analyses 
The analyses were aimed at answering the following questions: (a) Does EXP predict 
therapeutic outcomes? (b) Does EXP have the same predictive power across therapeutic 
approaches? (c) Are there other moderators between EXP and therapeutic outcomes?  
CHAPTER 3 
Results 
Included Studies  
An initial literature search of published literature on the topic of the Experiencing 
Scale and psychotherapy outcomes resulted in 176 articles that could potentially qualify 
to be included in the meta-analysis. An additional 14 articles were obtained through 
listserv responses from individual researchers. Of the total 190 articles, 179 did not meet 
the selection criteria (see methods section) and also revealed a surprisingly high amount 
of redundancy in the field (see Appendix B for details). Of the studies that failed to meet 
the criteria, 109 did not use the Experiencing Scale. Forty two studies did examine the 
relationship between EXP and some outcome, that outcome was defined in terms of small 
“o’s” (Greenberg & Pinsof, 1986), while only studies that predicted final treatment 
outcome could meet the selection criteria. Eight more studies were excluded because they 
featured overlapping data sets (as Appendix B indicates, there were more than eight 
studies with overlapping data sets, but some of those were excluded because they studied 
small “o’s”). Six studies did not study clinical outcomes, another six studies did not ha ve 
data convertible to effect size, four additional studies lacked vital information that was 
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requested but impossible to obtain (e.g., lost, destroyed), three studies were search 
duplicates, and one more study used EXP scale to validate another measure but did not 
link it to outcomes. 
In the end, of the remaining 11 suitable studies used for this meta-analysis, 7 were 
published and 4 were unpublished dissertations/theses. From this set of 11, additional 
information was requested and received for 6 of the selected studies. Thus, a total of 458 
clients from 11 studies were included in this meta-analysis. One of the studies (Hakim, 
2010) compared two completely separate datasets and was therefore treated as two 
separate studies for the purposes of the analyses. Relevant study characteristics are 
presented in Table 1. 
All of the 11 studies except one reported some form of inter-rater agreement rating 
for EXP data, and all but three indicated the amount of data that was subject to reliability 
check. Generally, at least 33% of data were checked (reliability samples ranging from 
33% to 100% overlapping data). Cohen’s Kappa and Intra-Class Correlation scores being 
in the good to excellent agreement range according to Fleiss (1981) and Fleiss (1986) 
benchmarks (e.g., kappa = .70 to .85). 
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Table 1 
 Study characteristics: Data sets and the reliability of EXP ratings 
Study N Publication 
Reliability of EXP ratings 
Data 
checked 
Cohen's 
Kappa 
Inter-
rater r 
Intra-Class 
Correlation 
Burgess (2012) 64 Unpublished 0.80   100% 
Greenberg (1983) 28 Published    n/a 
Hakim (2010; data 
set a) 
28 Unpublished 0.70 0.74  33% 
Hakim (2010; data 
set b) 
29 Unpublished 0.70 0.80  33% 
Makinen & Johnson 
(2006) 
24 Published 0.83   n/a 
Pachankis & 
Goldfried (2010) 
52 Published   0.88 n/a 
Pos et al. (2009) 73 Published 0.79   33% 
Ralston (2006) 30 Unpublished 0.84 0.92  33% 
Robichaud (2004) 37 Unpublished 0.85   33% 
Rudkin et al. (2007) 8 Published   0.85 33% 
Toukmanian et al. 
(2010) 
19 Published  0.89  53% 
Watson et al. (2011) 66 Published   0.83 69% 
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Distribution of Effect Sizes Across Studies 
While most studies conducted their ratings line-by- line (as dictated by the EXP 
manual), it has also become the convention to report findings in terms of either mode, 
peak (maximum EXP score), or both. The rationale for this in the literature is that mode is 
conventionally considered the best index of central tendency, while peak is considered an 
indicator of the upper limit of good process for a given therapy; and these are thought to 
be meaningful indices for clinical reasons (see Klien et al., 1986). Furthermore, many 
studies report the EXP scores at more than one point in the therapeutic process. 
Typically, EXP is measured early in therapy while the client-therapist rapport is being 
established (early phase), and later in treatment, when actual therapeutic work is being 
done (working phase).  
For the purposes of this study early phase EXP was defined as measured during 
sessions one to four, and working phase during sessions five to two sessions before 
termination. This assignment of session numbers was made by browsing what the 
researchers reported as Early and Working phase sessions across the included studies. 
Mode scores represent the most consistently expressed level of experiencing, while the 
Peak scores represent the deepest level of experiencing, a moment of emotional “insight”. 
This meta-analysis used four predictors: early phase mode EXP, early phase peak EXP, 
working phase mode EXP, and working phase peak EXP Stem-and- leaf plots of the effect 
sizes by these categories are in Figure 2. 
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Figure 2. Stem-and- leaf plots of study effect sizes for each predictor measure.  
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Publication Bias  
This meta-analysis addressed publication bias by contacting researchers for 
unpublished studies, both directly and through listserves. Of the 11 studies that were 
included in the meta-analyses four were unpublished (36.4%). Additionally, Orwin’s fail-
safe N was computed for each of the four predictors and their corresponding effect sizes 
(see Figure 2). The results are typically judged by a benchmark proposed by Rosenthal 
(1979): if the fail-safe N is greater than the cut-off of 5k + 10 (where k is the number of 
studies) then such a number of unpublished studies is unlikely to exist.  
For both early phase mode and peak effect sizes the fail-safe N was below zero. In 
terms of publication bias, this means that even if there are any unpublished studies with 
trivial effects they would not make any difference for the results if they were included in 
the analysis, because the observed effects in the early phase are already trivial. 
In the working phase the fail-safe N that would be needed to trivialize the effects 
found for mode was a hypothetical sample size of 31 studies, and for peak, a sample size 
of 57. While fail-safe N for the effects of mode does not exceed its cut-off and peak fail-
safe N does, given the specialized nature of the area and the effort put in obtaining the 
unpublished data, it is highly unlikely that such number of unpublished studies exists in 
reality. Thus, we feel that we have adequately addressed the publication bias. 
Individual Measures: EXP Process as a Predictor of Unique Treatment Outcomes  
For exploratory purposes, separate meta-analyses were carried out for individual 
psychometric measures. The following outcome measures were commonly used and 
could be compared and compiled across process-outcome studies: Beck Depression 
Inventory (BDI), Inventory of Interpersonal Problems (IIP), Rosenberg Self-Esteem 
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Scale (RSE), Symptom Checklist-90-Revised (SCL-90-R), and a special category we 
labeled expert Clinical Judgment.  
The “Clinical Judgment” category was assigned to an outcome measure when the 
outcome was decided based on some form of judgment by one or more expert clinicians 
(usually at some reported level of reliability) and this was done dichotomously, as in the 
resolution vs. non-resolution of a targeted personal or interpersonal problem (e.g.. 
following gestalt, or couples therapy). After selecting a sample of participants with each 
of these types of outcomes, the researchers would then use a backwards prediction to 
compare them on their respective levels of process as measured by the EXP. For 
example, Burgess (2012) compared couples that achieved a “softening event” vs. the 
couples that did not, where the softening event occurred when the blaming partner 
approached their partner from a position of vulnerability and was understood and 
supported. Burgess then compared the two groups on their respective levels of EXP. 
Whether the couple achieved the softening event was based on an expert clinician’s 
judgment as well as blind ratings by independent raters on a checklist of in-session 
softening event markers. Burgess (2012) found that softened couples had higher levels of 
EXP during their best (working phase) sessions than couples who did not soften toward 
each other. The correlational nature of this type of design allowed us to determine to what 
degree higher levels of EXP predict a softening event.  
The results of individual measure meta-analyses are summarized in Table 2, where k 
indicates the number of studies used for each analysis.  There is no clear variation in the 
pattern that emerges from the meta-analyses of individual outcome measures. Significant 
and non-significant results occurred during both early and working phase for mode and  
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Table 2 
Effect of EXP on individual outcome measures 
Outcome Predictor 
r-effect 
size 95% CI k p I2 
BDI Early Mode -0.133 -.270, .009 5 0.065 0.00 
 
Early Peak -0.177 -.330, .016 6 0.032 21.70 
 
Working Mode -0.256 -.437, .056 4 0.013 46.45 
 
Working Peak -0.250 -.457, -.019 5 0.035 61.36 
IIP Early mode -0.216 -.345, -.079 4 0.002 0.00 
 
Early peak -0.281 -.404, -.147 4 0.000 0.00 
 
Working mode -0.070 -.221, .084 3 0.372 0.00 
 
Working peak -0.237 -.376, -.086 3 0.002 0.00 
RSE Early mode 0.117 -.138, .358 4 0.369 70.88 
 
Early peak 0.179 -.078, .414 4 0.171 71.36 
 
Working mode 0.183 .031, .327 3 0.019 0.00 
 
Working peak 0.179 -.168, .486 3 0.311 78.88 
SCL-90-R Early mode -0.097 -.308, .123 7 0.387 71.74 
 
Early peak -0.161 -.270, -.048 7 0.005 74.68 
 
Working mode -0.141 -.305, .031 5 0.109 34.82 
 
Working peak -0.266 -.425, -.092 5 0.003 40.12 
Clinical Early mode 0.137 -.074, .335 2 0.203 0.00 
Judgment Early peak 0.246 - 1 - - 
 
Working mode 0.724 .457, .871 2 0.000 70.11 
 Working peak 0.882 .383, .983 2 0.006 93.64 
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peak scores across the measures. Overall, the effect sizes had a generally consistent 
magnitude, with an exception of the clinical judgment measure that showed extremely 
large correlations with EXP (an issue that we will return to later).  
 As shown in table 2, a significant I2 heterogeneity among the effect sizes was 
present in some form for all of the measures, except for the Inventory of Interpersonal 
Problems (IIP). Normally, such heterogeneity would be further explored through 
moderator analysis. However, because of a small number of studies, moderator analysis 
for each of the individual measures was not a feasible strategy. The next step in analysis 
was the search for the overall predictive power of EXP. This was done by pooling the 
effect sizes within each study to compute a total index.  
Total Index: EXP Process as an Overall Predictor of Treatment Outcome  
The total index was obtained by taking the mean effect sizes across individual 
measures for each of the 11 suitable studies, and therefore represents a general clinical 
outcome. Because high scores on some measures indicate improvement in symptoms 
(e.g., Rosenberg Self Esteem), while high scores on others signal greater impairment 
(e.g., Beck Depression Inventory), the absolute value of correlation was used for the 
calculation of the total index. Because greater EXP is hypothesized to correlate with 
betterment of symptoms, when the actual correlation was not in the predicted direction, it 
was entered as a negative value and therefore detracted from the overall predictive power.  
The results are shown in Table 3 for each phase of therapy.  During the early phase, 
peak EXP was significantly associated with the total index, r = .124, p = .048. The 
amount of dispersion of effect sizes was low, I2 = 21.2%, and did not exceed what would  
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Table 3 
Total Index: Overall predictive power of EXP 
Predictor Mean r-effect size 95% CI k p I2 
Early Mode 0.093 -0.007, 0.191 10 0.0674 0.0 
Early Peak 0.124 0.001, 0.243 10 0.0475 21.2 
Working Mode 0.350 0.084, 0.567 7 0.0108 82.6 
Working Peak 0.447 0.095, 0.670 8 0.0146 90.1 
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be expected by chance, Q (9) = 11.416, p = .248. Early in therapy, mode EXP was not 
found to be a statistically significant predictor of outcomes, r = 0.093, p = 0.067. 
Working phase peak EXP was found to have the largest relationship with the total 
index, r = .447, p = .015, with a very high amount of effect size dispersion, I2 = 90.1%. It 
was followed by working phase mode EXP, r = .350, p = 0.011, with similarly high 
dispersion, I2 = 82.6%. In both instances the confidence intervals were very wide.  
Moderator Analysis 
Clinical Judgments as a Moderator in EXP’s Prediction of Outcome.  
High heterogeneity for working phase mode and peak EXP effect sizes warranted 
further investigation. Visual inspection of effect sizes confirmed the suspicion that there 
often were extremely large effect sizes of EXP on clinical judgment outcomes during the 
working phase, which is believed to be the reason for the observed dispersion of effect 
sizes. To investigate further, subgroup analyses were done that compared those studies 
that used clinical judgment to those that did not (results are presented in Table 4). The 
general finding is, studies that used clinical judgment as an evaluation of treatment 
outcomes had a much higher average effect size than studies that did not. This difference 
was significant for both mode and peak EXP (Q(1) = 11.226, p < 0.001, and Q(1) = 
5.126, p = 0.024, respectively). It is worthwhile to note that there were a total of three 
studies that used clinical judgment, and all were aligned with the experiential tradition 
(Burgess, 2012; Greenberg, 1983; Makinen & Johnson, 2006). Two of them were on 
experiential couples therapy. 
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Table 4  
Effect of EXP based on whether Clinical Judgment outcome was used 
Variable 
Clinical 
Judgment as 
outcome (k) 
Mean r-
effect size 
95% CI I2 Q p 
Working Mode  Not used (5) 0.157 0.023, 0.285 0.0 11.226 0.0008 
 
Used (2) 0.724 0.457, 0.871 70.1 
  Working Peak Not used (5) 0.236 0.110, 0.355 0.0 5.126 0.0236 
  Used (2) 0.882 0.383, 0.983 93.6 
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Therapeutic Approach as a Moderator in EXP’s Prediction of Outcome. 
Subgroup analysis was used to establish whether the predictive power of EXP varies 
for different therapeutic approaches. Given that EXP is a construct that is derived from an 
experiential approach to psychotherapy, it seems particularly useful to examine whether 
predicative power of EXP on treatment outcomes is different across treatment 
approaches. Of the 11 process-outcome studies used in this meta-analysis, seven studies 
fit under the rubric of “experiential psychotherapy” and three represented multiple 
approaches that could be grouped under the heading “non-experiential therapy” (Hakim, 
2010, compared two such treatments in the same study, IPT vs. CBT; Rudkin et al., 2007, 
compared CBT vs. psychodynamic- interpersonal therapy). Finally, one more study 
(Watson & Bedard, 2006) reported both experiential and non-experiential treatment 
comparisons in the same study (i.e., EFT vs. CBT). Thus, these studies yielded 13 
independent data sets in total: eight on experiential therapy and five on non-experiential 
intervention approaches. Additionally, one of the studies (Watson et al., 2011) reported 
combined statistics for its EFT and CBT subgroups. Because of that, a related study that 
used a slightly smaller and overlapping dataset (Watson & Bedard, 2006) was substituted 
as it reported separate statistics for its EFT and CBT subgroups. This is the only instance 
when we used a study with an overlapping dataset (although in this case each study is 
used to uniquely address different research questions). See Figure 3 for details on specific 
treatment modalities. Given that clinical judgment outcomes have very large effect sizes 
and were only used by experiential studies, it was necessary to control for this 
confounding variable. Therefore, clinical judgment outcome studies were not used for  
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Figure 3. Treatment approaches and corresponding data sets.  
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this comparison, and all reported effects only reflect the relationship between process and 
symptom-based outcomes. 
The predictive power of EXP was compared between experiential and non-
experiential treatment studies with the Q heterogeneity test. The results are summarized 
in Table 5. The subgroup analysis indicated that peak EXP scores had a significantly 
greater predictive power for experiential studies as opposed to non-experiential studies 
(difference r = .278) during the early phase of treatment (Q(1) = 5.527, p = 0.019). Lack 
of other significant differences may reflect a small number of non-experiential studies 
and low statistical power. 
Treatment Target as a Moderator in EXP’s Prediction of Outcome.  
Treatment studies can also be divided along the lines of target complains or the focus 
of treatment. While EXP has been discussed in the literature as a useful process for 
general therapeutic progress, it seems useful to conduct a subgroup analysis to examine 
whether the predictive power of EXP varies for different clusters of treatment concerns. 
Of the 13 data sets used in this meta-analysis (described above), six were specifically 
concerned with the treatment of “depression,” while seven were from studies that treated 
“interpersonal problems/trauma” (i.e., 2 treated complex relational trauma, 2 treated 
stressful interpersonal difficulties, 1 for prejudice-related trauma, and 2 used a couples 
modality of therapy). All three studies (including both couples therapies) that used 
clinical judgment as outcomes were also addressing “interpersonal problems/trauma”. To 
remove this confound, these three studies were excluded from the analyses and the 
examined relationships only reflected the prediction of symptom-based outcomes. 
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Table 5 
Effect of EXP based on type of treatment: Experiential vs. non-experiential therapy 
Variable Treatment (k) 
Mean r-
effect size 95% CI Q p 
Early Mode Experiential (4) .162 -.001, .317 1.618 0.203 
 
Non-experiential (5) .005 -.174, .183 
  
      Early Peak Experiential (5) .203 .053, .344 5.527 0.019 
 
Non-experiential (5) -.075 -.247, .102 
  
      Working Mode Experiential (3) 0.206 0.025, 0.373 0.059 0.808 
 
Non-experiential (3) 0.170  -0.066, 0.388 
  
      Working Peak Experiential (4) 0.233 0.066, 0.388 0.335 0.563 
  Non-experiential (3) 0.150 -0.086, 0.370     
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In this way, the predictive power of EXP was compared between studies on 
individual therapies for depression vs. interpersonal problems/trauma with the Q 
heterogeneity test. The results are summarized in Table 6. The subgroup analysis 
indicated that only during the early phase of treatment, mode EXP was a better predictor 
of outcomes in studies that addressed depression as opposed to interpersonal 
problems/trauma (Q(1) = 4.212, p = 0.040). It was impossible to make a comparison for 
working phase mode because of insufficient k. No other significant differences were 
found. 
CHAPTER 4 
Discussion 
While the Experiencing Scale has often been referred to by process researchers as 
one of the best process measures to be predictive of outcomes, there has been no 
systematic review of it. In addition, a convention has been carried forward based on the 
clinical intuition of Klein et al. (1986) that EXP be reported using two different statistics: 
mode and peak. While researchers typically report both, sometimes they favor mode over 
peak in their analyses with the argument that a central tendency is more representative of 
what has happened in therapy. This however, should be an empirical question rather than 
one of rational theory, yet there has been no systematic evaluation of which EXP statistic 
is a better predictor of outcomes. To complicate matters further, EXP scores taken at the 
beginning of therapy may essentially represent different processes than those measured 
later in therapy, when the therapeutic alliance has been well established and some 
therapeutic work has been accomplished. As Pos et al. (2009) note, early EXP represents 
the baseline emotional processing capacity when clients first enter therapy, while  
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Table 6 
     Treatment target as a moderator of EXP's prediction of outcome 
  
Variable Target (k) 
Mean r-
effect size 95% CI Q p 
Early Mode Depression (6) .192 .039, .336 4.212 0.040 
 
Interpersonal (3) -.060 -0.242, 0.126 
  
      Early Peak Depression (6) .136 -.036, .300 0.809 0.369 
 
Interpersonal (4) .018 -.173, .207 
  
      Working Mode* Depression (5) - - - - 
 
Interpersonal (1) - - 
  
      Working Peak Depression (5) .243 .090, .384 1.125 0.289 
  Interpersonal (4) .065 -.230, .349     
*Insufficient k  for the analysis.  
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working phase EXP represents the process of change, or deepening of emotional 
processing. 
The results indicated that EXP measured during the early phase of therapy (sessions 
one to four) is not a strong predictor of ultimate therapy outcomes. When EXP was 
measured during the working phase of therapy (session five to two sessions before 
termination) EXP is indeed predictive of eventual outcomes, with peak EXP having a 
higher average effect size. Measuring outcome by way of clinical judgment (e.g., 
resolved vs. unresolved personal issues) was found to be an important moderator for the 
working phase predictors.  
I briefly discuss this issue of the measurement moderator using peak EXP as an 
example, but the same conclusions apply to mode EXP findings as well. In short, the 
summary effect size that does not take this moderator into account (r = .447) can be 
misleading. An extremely wide confidence interval indicates that there are really two 
different populations of data: that of the pen-and-paper psychometric measures (i.e., Beck 
Depression Inventory) which are predicted by EXP to some degree (r = .236), and that of 
clinical judgment, an expert opinion, which shows EXP to have much more predictive 
power (r = .882). This disparity cannot be easily reduced to researcher/judge bias given 
that clinical judgments on treatment outcome were always subject to ratings by separate 
judges (and corroborated by client self-report). An important caveat is that only one study 
out of three provided an index of reliability for clinical judgments and explicitly stated 
methodological precautions to ensure that such clinical judgments were also blind to 
treatment outcome. 
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Perhaps more critically, these approaches of measuring outcomes come from 
different assessment modalities and probably capture separate aspects of change that 
happens in therapy. It is possible that clinical judgment is a measure that is more sensitive 
to “true” change, or more of a personalized evaluation in a way that measures such as 
BDI are not. In fact, clinical judgment is the most "process-based" outcome measure. It is 
also the only evaluation of outcome that is based on actually viewing in-session 
performance to evaluate the treatment's success. This is a categorically different modality 
of assessment and may be more sensitive to the true or “lived” outcome, as clients 
grapple moment-by-moment with their troubles. That being stated, there were only two 
studies that measured working phase EXP and related it to clinical judgment outcome, so 
drawing any strong inferences about just a couple of studies is problematic. As such, 
relationship between the pen-and-paper measures and EXP is a more conservative and 
precise estimate of EXP’s predictive power.  
Implications for Research and Practice 
Among known common factors, the therapeutic alliance is the most well-established 
predictor of in-session process on psychotherapy outcomes, with a correlation within .22 
to .29 range (Horvath, 2005). This offers a point of comparison or context for our finding: 
Client’s peak EXP during the working phase of therapy as a predictor of post-treatment 
symptom reports has average effect in the range of .11 to .36 (95% CI), which is a 
correlation comparable to that of the working alliance. Thus, it is possible that client 
experiencing, as measured by the EXP, is another common factor of a similar magnitude 
and importance as the alliance, so further research on it will be a worthwhile investment 
for theory and practice of clinical psychology.  
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Furthermore, alliance and EXP clearly represent different constructs as demonstrated 
by a number of carefully controlled studies. For example, Ralston (2006) found 
correlations of r = -.003 and r = .185 between mode and peak EXP and alliance at pre-
treatment. Similarly, Watson et al. (2011) found that correlations with the working phase 
alliance were r = .13 during the early phase for both mode and peak EXP, and r = .15 for 
mode and r = .29 for peak EXP during the working phase. Finally, Pos et al. (2009) found 
that alliance correlates with EXP at r = -.05 during the early phase and at r = .32 during 
the working phase. These findings suggest that, at least in experiential therapies, there 
seems to be little to no relationship early in treatment, and then a small to moderate 
relationship eventually emerges over time.  
In short, this suggests there is some relationship between these two different 
constructs, and they are not likely to be redundant with one another. Further to this point, 
the predictive power of EXP can be measured in the total absence of any therapeutic 
alliance as is demonstrated in the expressive writing study of Pachankis and Goldfried 
(2010). In psychotherapy research and theory, the alliance has been tentatively described 
as probably having a conditional relationship with deeper levels of experiencing, such 
that a strong alliance may provide a safe environment conducive to deeper levels of 
experiencing (Paivio & Pascual-Leone, 2010; Pos, Greenberg, Goldman, & Korman, 
2003). Alliance was also considered within a mediational framework, such that during the 
working phase the relationship between therapeutic alliance and the outcomes was 
partially mediated by client experiencing (Pos et al., 2009). As such, the covariation of 
the alliance and other known process variables with EXP is also of interest. Furthermore, 
it is likely that the therapeutic alliance moderates the relationship between experiencing 
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and outcomes, such that experiencing predicts better outcomes only when therapeutic 
alliance is sufficiently strong. 
Limitations 
These results should be considered while keeping in mind the limitations of 
correlational research and a very modest sample size. In case of significant correlations, it 
is possible that some other variable is fully or partially responsible for the relationship, 
such as therapeutic alliance, which we have discussed as a powerful common factor. 
Given a small number of studies it was impossible to control for this or other possible 
confounding factors. Another implication of having only 11 suitable outcome studies is 
that the summary effect sizes are estimated with less precision (i.e., the confidence 
intervals are wider) than would be the case if more studies were available. Finally, the 
statistical significance tests (such as Q tests) may be underpowered (Borenstein et al., 
2009). 
Another caveat to consider is lack of significant association between process and 
outcome, which occurs in the early phase mode EXP. The causal relationship may be 
there but possibly hidden by the highly interactive nature of psychotherapy. Stiles (1988) 
has described this phenomenon as the within-study variation in client requirements and 
corresponding therapist responsiveness. Essentially, in an effective therapy, a client with 
greater needs (e.g., a need for deeper experiencing, bodily-awareness, meaning-making) 
will be met with higher responsiveness from a psychotherapist using interventions and a 
therapeutic focus that is related to that need. So if a client needs constant validation of an 
emerging experience to get better (high requirement), a good psycho therapist will provide 
it frequently (high process). Similarly, if the client does not need constant validation to 
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get better (low requirement), a psychotherapist will move on to something more pressing, 
keeping the number of validations relatively low (low process). This responsivity is 
clearly more sophisticated than the “more process is better” models of change. 
Unfortunately, however, limited factors and contexts further complicate the issue: For 
example, a client with exceptionally high requirements is less likely to have his or her 
requirements fully met, resulting in a poorer outcome, despite receiving a higher overall 
level of validations. Finally, client requirements and therapist responsiveness may vary 
within and between therapy sessions, such that the “true” relationship for each individual 
is actually part of a dynamic process in time. Thus, a group average of measured 
relationships between process and outcome may be diluted or even reversed, masking 
meaningful case-by-case relationships. In conclusion, it is possible that the true 
relationship between EXP and outcomes is actually higher than what the research designs 
and effect sizes in this meta-analysis have indicated. 
Future Research 
This meta-analysis identified a number of challenges to current process research. A 
significant issue is that of overlapping datasets. Thirteen of the studies considered for this 
meta-analysis had samples that were shared with at least one other study (see Appendix 
B). When this occurred, a newer study with slightly different research questions would 
typically expand on the dataset used by the older one: either by (a) adding new 
participants or sampling methods (e.g., Pos et al., 2009, increases the sample size of Pos 
et al., 2003, which had also been used by Goldman et al., 2005) or (b) adding new 
comparison groups (e.g., Hakim, 2010, includes the same sample as Pos et al., 2003, and 
also compares these to rating of a different archival data set from Elkin et al., 1989). 
 44 
 
 
While each individual study has made important contributions, this practice as a whole is 
problematic for a variety of reasons. First, the issue is often inadvertently obscured by the 
fact that an exact percent overlap among process studies using the same archival data sets 
is often undeclared and this could only be discerned in our study by personal 
communications with researchers. Second, in a study such as this if the overlapping 
datasets were mistakenly used they would violate the assumption of independence of 
observations, not only because the same people are used across the data sets, but also 
sometimes even the same EXP ratings and often the same outcome measures scores. 
Generally, researchers have acknowledged the redundancy of the data sets used in their 
studies; however, it would be desirable if more information were given, such as percent 
of overlapping data. 
Although EXP has a magnitude of effect comparable to the therapeutic alliance, to be 
respected to the same degree it needs to have more support from studies that use a variety 
of treatments, outcome measures, and most importantly, different participants. With more 
studies of this kind an estimate of the predictive power of EXP can be defined much more 
precisely. Moreover, EXP is a measure of the “client experiencing” construct that can be 
measured by other means, such as the Client Emotional Productivity Scale developed by 
Greenberg, Auszra, and Herrmann (2007). The construct as a whole deserves more 
attention from individual studies, and as suggested earlier, would benefit from research 
designs incorporating multiple measures of client experiencing in a structural equation 
framework. A similar suggestion concerns the outcome measures. Given the results of 
this meta-analysis, EXP has different relationship with different modalities of outcomes. 
It is possible that some effects may be lost because only paper-and-pencil measures are 
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included, while others may perhaps be overstated because of the use of expert opinion as 
an outcome. Incorporating multiple outcome modalities as well as multivariate analyses 
would be a welcome addition to the field.  
 While this study has produced important findings on the role of EXP process-to-
outcome (final treatment outcome), the original proposal aspired to also examine the role 
of other client and therapist in-session processes as predictors of EXP. This extension has 
not been possible given the time limits of this project and the intensive nature of coding. 
There are an estimated 32 studies that would potentially qualify for the process-to-
process meta-analysis. However, as stated earlier, significant predictive power of EXP 
justifies such process-to-process study. Given that EXP correlates with final treatment 
outcomes, it would be useful for practitioners to know how exactly they can increase 
client experiencing while working in-session. Therapists do not have control over the 
baseline client experiencing levels, and the effects of early experiencing on final 
outcomes were found to be trivial to small. That is not the case with working phase client 
experiencing. As stated earlier, experiencing in the working phase represents a process of 
change from the baseline levels. Assuming therapists can influence this change by some 
intervention strategies (therapist processes), such as empathic responding or validation, 
they can shape the outcomes. If the process-to-process study were to be done, its focus 
should be on working phase EXP, particularly the peak scores, as they show a bigger 
effect on outcome. The results of such study would complement this meta-analysis in 
informing practitioners what they can do to help their clients beyond the specific 
interventions of any given therapeutic approach.  
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Finally, given that EXP is a potential common factor, its predictive power should be 
investigated across therapeutic modalities and controlled for potential confounds. More 
specifically, it can be beneficial to see how therapeutic alliance and EXP interact with 
each other in predicting the outcomes.  
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List of contacted researchers 
Beck, A. Chicago Group Development Research Team. 
Burgess Moser, M. University of Ottawa. 
Caspar, F. University of Bern.  
Ellis, L. Chicago School of Professional Psychology.  
Grindler-Katonah, D. Argosy University American School of Professional Psychology.  
Hakim, L. Z. University of Windsor. 
Johnson, S. University of Ottawa. 
Klug, G. University of Zurich. 
Kray, T. North Central Bronx Hospital.  
Levitt, H. University of Massachusetts.  
Llewelyn, S. University of Oxford. 
Pachankis, J. Yeshiva University. 
Paivio, S. University of Windsor. 
Pos, A. York University. 
Ralston, M. University of Windsor.  
Robichaud, L. University of Windsor.  
Rudkin, A. University of Southampton.  
Stiles, W. University of Ohio. 
Toukmanian, S. York University.  
Vanaerschot, G. University of Antwerp.  
Wongpakaran, T. Chiang Mai University. 
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APPENDIX B  
Studies presented by data taken from research centers 
York University OISE 
University of 
Ottawa 
NIMH** 
Pos & Escobar (2011) 
*Watson et al. 
(2011) 
*Makinen & 
Johnson (2006) 
Missirlian 
(2011) 
*Pos et al. (2009) 
 
Watson & 
Bedard (2006) 
Makinen (2005) *Hakim (2010) 
Goldman et al. (2005) 
  
Jackson (2011) 
Pos et al. (2003) 
   
Levitt et al. (2000) 
   
Watson & Greenberg 
(1996) 
      
*Chosen as primary study for this meta-analysis. 
**Studies that used NIMH data set also used York University data set, but only NIMH data was 
used for the meta-analysis. 
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